Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder. - Wikidata - wikimedia - TriplyDB

Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.

Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.

http://www.wikidata.org/entity/Q37688083

about

From Thought to Action: How the Interplay Between Neuroscience and Phenomenology Changed Our Understanding of Obsessive-Compulsive Disorder The neurobiological link between OCD and ADHD Cognitive enhancers for anxiety disorders.Obsessive-Compulsive Disorder and Autism Spectrum Disorders: Longitudinal and Offspring Risk.Neuroenhancement of Exposure Therapy in Anxiety Disorders.An integrated molecular landscape implicates the regulation of dendritic spine formation through insulin-related signalling in obsessive-compulsive disorder.Management of obsessive-compulsive disorder comorbid with bipolar disorder.Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for clinicians.Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature.Symmetry symptoms in obsessive-compulsive disorder: clinical and genetic correlates.Is nocturnal eating in restless legs syndrome linked to a specific psychopathological profile? A pilot study.Nucleus accumbens high-frequency stimulation selectively impacts nigrostriatal dopaminergic neurons.Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity.Postpartum Lactation-Mediated Behavioral Outcomes and Drug Responses in a Spontaneous Mouse Model of Obsessive-Compulsive Disorder.Vitamin D levels in children and adolescents with obsessive compulsive disorder.Cane Toad Skin Extract-Induced Upregulation and Increased Interaction of Serotonin 2A and D2 Receptors via Gq/11 Signaling Pathway in CLU213 Cells.Monoamine abnormalities in the SAPAP3 knockout model of obsessive-compulsive disorder-related behaviour.

P2860

Q26774751-9C139632-F77A-455D-94A2-031FA8863B14 Q27002629-9A079F8A-3E0C-45E9-B4C3-761DA87A15BD Q35043125-422F8D22-B697-41E2-AE32-7E7A2B7F1A62 Q35838520-E018C725-67AC-4011-AB68-23E65FC1B1AF Q35985350-20765A58-85FA-4C2C-822A-5E9554EDBFD5 Q37026324-5E03D580-7E76-4F82-830C-EE76A66F7066 Q37400532-229AB2C5-1177-4291-8370-DA6A2BD8F865 Q38236029-1A94DC86-C214-4B8B-8C53-00DA0D701134 Q38254316-C58CE630-79E2-4815-9A49-A6E8B60510C8 Q40624774-A7F799E2-7B95-45CC-A4E3-3B75E393C8E3 Q41522809-73830D86-F25E-4B6B-8E67-8A11BA497B3C Q41897719-3D6CE742-B1C9-4AD4-B334-B2BE8667516E Q42057773-FE173926-D54A-41CD-B763-9AFC3A88C431 Q47614008-FBC1F219-AC97-404F-B382-54F6D8511593 Q47698811-05B964BD-40FF-40AC-A094-CC0D98A1DE08 Q48682603-A9CA209E-D653-4B89-A98E-1B7F582B7929 Q53468951-D0A7449B-595D-49A6-AF06-600C5511FC06

P2860

Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.

http://www.wikidata.org/entity/Q37688083

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.

@en

Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.

@nl

type

label

Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.

@en

Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.

@nl

prefLabel

Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.

@en

Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.

@nl

P1433

Q37688083-2ED6B227-C710-49C0-95C5-1955020137E3

P1476

Q37688083-B81BE928-7A13-462A-A50F-45A3BCBB4B4D

P2093

Q37688083-6F370F42-4F05-403F-B0FF-A0EC15EA4ED1

Q37688083-980BF698-3260-4D8A-9AC4-3970BB2CBC2D

Q37688083-C189B3BC-A0AB-417F-B321-AF3444F86680

Q37688083-FBB7E1AE-72C4-45D6-9056-B88C5887F962

P2860

Q37688083-01830974-E0EC-406B-AA3D-D93CB30F0937

Q37688083-0BBBB7FC-5ACF-48B2-8D88-35BDE9FE6E63

Q37688083-11D65C61-040B-438F-B21A-E8FD4ED95536

Q37688083-15631D29-3D00-4F71-BB77-04F737B7BCF8

Q37688083-157DB258-2CDF-4344-BA06-5E4EC58A26F2

Q37688083-18302EE3-F62D-4D99-812D-ABFA99C18753

Q37688083-1B5687C5-2089-47F5-9C41-17343E61B68F

Q37688083-1D7495F0-0917-4764-8614-89D376B5FB18

Q37688083-1EBE3E33-EE33-4B80-BE09-4E6C8385B143

Q37688083-1FD6528E-6FD1-4526-B232-621955677A6F

P304

Q37688083-A10551CB-D04F-4753-8403-404AFE872CBA

P31

Q37688083-CE538C45-FE09-43EB-864A-53A9A9306256

P356

Q37688083-57126B75-4A33-463E-837E-4F0236C8F357

P433

Q37688083-94030F45-FC05-4A4C-BD65-0DB2DF8D7829

P478

Q37688083-6847B769-11BF-41B4-A48D-38ACCAFB57F5

P577

Q37688083-1D0D4D1B-998C-490F-98E8-DEADC135EC01

P698

Q37688083-714DD246-FBB4-449E-9262-6B95B632034B

P921

Q37688083-317f09f8-06a6-428d-a6aa-ef250930ba2a

Q37688083-85E8CA2B-9648-4CB3-8054-EBE4405900A6

P356

P1433

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

P1476

Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.

@en

P2093

Chan-Hyung Kim

http://www.w3.org/2001/XMLSchema#string

Daeyoung Roh

http://www.w3.org/2001/XMLSchema#string

Eun-Ju Kim

http://www.w3.org/2001/XMLSchema#string

Min-Seong Koo

http://www.w3.org/2001/XMLSchema#string

P2860

Orbital Frontal and Amygdala Volume Reductions in Obsessive-compulsive Disorder

Dopamine Transporter Density in the Basal Ganglia in Obsessive-Compulsive Disorder, Measured with [123I]IPT SPECT before and after Treatment with Serotonin Reuptake Inhibitors

Enhanced Dopamine Transporter Density in Psychotropic-Naive Patients With Obsessive-Compulsive Disorder Shown by [ 123 I]β-CIT SPECT

Contemporary assessment and pharmacotherapy of Tourette syndrome

Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder

Disruptive behavior in children with Tourette's syndrome: association with ADHD comorbidity, tic severity, and functional impairment

Obsessive-compulsive symptoms with olanzapine

Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited.

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.

Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship.

P304

275-290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERN.09.148

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20136383

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology